Shopping Cart 0
Cart Subtotal
AED 0

Global Active Pharmaceutical Ingredient Market Analysis 2013-2018 and Forecast 2019-2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 10937

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 21873

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 21873
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Snapshot

Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug.

The global Active Pharmaceutical Ingredient market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Active Pharmaceutical Ingredient by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Synthetic API

Biotech API

Others

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Teva

Novartis

Pfizer

Johnson & Johnson

Mylan

North China Pharmaceutical Group

Dr. Reddy's Laboratories

Roche

Aurobindo pharma

Sun Pharmaceutical Industries

Boehringer Ingelheim GmbH

Bayer

BASF

DSM

Zhejiang Medicine

Biocon

Johnson Matthey

Hisun Pharmacy

Cambrex

Shandong Xinhua Pharmaceutical

Lonza group

Huahai Pharmaceutical

Haerbin Pharmaceutical Group

Cipla

Tian Yao

Lupin

North East Pharmaceutical

Albemarle

Shandong Lukang Pharmaceutical

Jiangsu Hengrui Medicine

Bachem

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Non-steroidal Anti-inflammatory Drugs (NSAIDs)

Oncology Drugs

Anti-diabetic Drugs

Cardiovascular Drugs

Central Nervous System Drugs (CNS Drugs)

Musculoskeletal Drugs

Other Drugs

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Table Of Content

Scope

Table of Contents

1 Industry Overview

1.1 Active Pharmaceutical Ingredient Industry

1.1.1 Overview

1.1.2 Development of Active Pharmaceutical Ingredient

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Active Pharmaceutical Ingredient Market by Type

3.1 By Type

3.1.1 Synthetic API

3.1.2 Biotech API

3.1.3 Others

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Active Pharmaceutical Ingredient Teva (Company Profile, Sales Data etc.)

4.2 Novartis (Company Profile, Sales Data etc.)

4.3 Pfizer (Company Profile, Sales Data etc.)

4.4 Johnson & Johnson (Company Profile, Sales Data etc.)

4.5 Mylan (Company Profile, Sales Data etc.)

4.6 North China Pharmaceutical Group (Company Profile, Sales Data etc.)

4.7 Dr. Reddy's Laboratories (Company Profile, Sales Data etc.)

4.8 Roche (Company Profile, Sales Data etc.)

4.9 Aurobindo pharma (Company Profile, Sales Data etc.)

4.10 Sun Pharmaceutical Industries (Company Profile, Sales Data etc.)

4.11 Boehringer Ingelheim GmbH (Company Profile, Sales Data etc.)

4.12 Bayer (Company Profile, Sales Data etc.)

4.13 BASF (Company Profile, Sales Data etc.)

4.14 DSM (Company Profile, Sales Data etc.)

4.15 Zhejiang Medicine (Company Profile, Sales Data etc.)

4.16 Biocon (Company Profile, Sales Data etc.)

4.17 Johnson Matthey (Company Profile, Sales Data etc.)

4.18 Hisun Pharmacy (Company Profile, Sales Data etc.)

4.19 Cambrex (Company Profile, Sales Data etc.)

4.20 Shandong Xinhua Pharmaceutical (Company Profile, Sales Data etc.)

4.21 Lonza group (Company Profile, Sales Data etc.)

4.22 Huahai Pharmaceutical (Company Profile, Sales Data etc.)

4.23 Haerbin Pharmaceutical Group (Company Profile, Sales Data etc.)

4.24 Cipla (Company Profile, Sales Data etc.)

4.25 Tian Yao (Company Profile, Sales Data etc.)

4.26 Lupin (Company Profile, Sales Data etc.)

4.27 North East Pharmaceutical (Company Profile, Sales Data etc.)

4.28 Albemarle (Company Profile, Sales Data etc.)

4.29 Shandong Lukang Pharmaceutical (Company Profile, Sales Data etc.)

4.30 Jiangsu Hengrui Medicine (Company Profile, Sales Data etc.)

4.31 Bachem (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Non-steroidal Anti-inflammatory Drugs (NSAIDs)

6.1.2 Demand in Oncology Drugs

6.1.3 Demand in Anti-diabetic Drugs

6.1.4 Demand in Cardiovascular Drugs

6.1.5 Demand in Central Nervous System Drugs (CNS Drugs)

6.1.6 Demand in Musculoskeletal Drugs

6.1.7 Demand in Other Drugs

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Active Pharmaceutical Ingredient Market Growth 2013-2018, by Type, in USD Million

Figure Global Active Pharmaceutical Ingredient Market Growth 2013-2018, by Type, in Volume

Figure North America Active Pharmaceutical Ingredient Market Concentration, in 2018

Figure Europe Active Pharmaceutical Ingredient Market Market Concentration, in 2018

Figure Asia-Pacific Active Pharmaceutical Ingredient MMarket Concentration, in 2018

Figure South America Active Pharmaceutical Ingredient Market Concentration, in 2018

Figure Middle East & Africa Active Pharmaceutical Ingredient Market Concentration, in 2018

Figure Active Pharmaceutical Ingredient Demand in Non-steroidal Anti-inflammatory Drugs (NSAIDs), 2013-2018, in USD Million

Figure Active Pharmaceutical Ingredient Demand in Non-steroidal Anti-inflammatory Drugs (NSAIDs), 2013-2018, in Volume

Figure Active Pharmaceutical Ingredient Demand in Oncology Drugs, 2013-2018, in USD Million

Figure Active Pharmaceutical Ingredient Demand in Oncology Drugs, 2013-2018, in Volume

Figure Active Pharmaceutical Ingredient Demand in Anti-diabetic Drugs, 2013-2018, in USD Million

Figure Active Pharmaceutical Ingredient Demand in Anti-diabetic Drugs, 2013-2018, in Volume

Figure Active Pharmaceutical Ingredient Demand in Cardiovascular Drugs, 2013-2018, in USD Million

Figure Active Pharmaceutical Ingredient Demand in Cardiovascular Drugs, 2013-2018, in Volume

Figure Active Pharmaceutical Ingredient Demand in Central Nervous System Drugs (CNS Drugs), 2013-2018, in USD Million

Figure Active Pharmaceutical Ingredient Demand in Central Nervous System Drugs (CNS Drugs), 2013-2018, in Volume

Figure Active Pharmaceutical Ingredient Demand in Musculoskeletal Drugs, 2013-2018, in USD Million

Figure Active Pharmaceutical Ingredient Demand in Musculoskeletal Drugs, 2013-2018, in Volume

Figure Active Pharmaceutical Ingredient Demand in Other Drugs, 2013-2018, in USD Million

Figure Active Pharmaceutical Ingredient Demand in Other Drugs, 2013-2018, in Volume

Figure North America Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in USD Million

Figure North America Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in Volume

Figure Europe Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in USD Million

Figure Europe Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in Volume

Figure South America Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in USD Million

Figure South America Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Active Pharmaceutical Ingredient

Table Application Segment of Active Pharmaceutical Ingredient

Table Global Active Pharmaceutical Ingredient Market 2013-2024, by Application, in USD Million

Table Major Company List of Synthetic API

Table Major Company List of Biotech API

Table Major Company List of Others

Table Global Active Pharmaceutical Ingredient Market 2013-2018, by Type, in USD Million

Table Global Active Pharmaceutical Ingredient Market 2013-2018, by Type, in Volume

Table Global Active Pharmaceutical Ingredient Market Forecast 2019-2024, by Type, in USD Million

Table Global Active Pharmaceutical Ingredient Market Forecast 2019-2024, by Type, in Volume

Table Teva Overview List

Table Active Pharmaceutical Ingredient Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Active Pharmaceutical Ingredient Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Active Pharmaceutical Ingredient Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Active Pharmaceutical Ingredient Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mylan Overview List

Table Active Pharmaceutical Ingredient Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table North China Pharmaceutical Group Overview List

Table Active Pharmaceutical Ingredient Business Operation of North China Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Dr. Reddy's Laboratories Overview List

Table Active Pharmaceutical Ingredient Business Operation of Dr. Reddy's Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Roche Overview List

Table Active Pharmaceutical Ingredient Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Aurobindo pharma Overview List

Table Active Pharmaceutical Ingredient Business Operation of Aurobindo pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sun Pharmaceutical Industries Overview List

Table Active Pharmaceutical Ingredient Business Operation of Sun Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Boehringer Ingelheim GmbH Overview List

Table Active Pharmaceutical Ingredient Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayer Overview List

Table Active Pharmaceutical Ingredient Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table BASF Overview List

Table Active Pharmaceutical Ingredient Business Operation of BASF (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table DSM Overview List

Table Active Pharmaceutical Ingredient Business Operation of DSM (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Zhejiang Medicine Overview List

Table Active Pharmaceutical Ingredient Business Operation of Zhejiang Medicine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Biocon Overview List

Table Active Pharmaceutical Ingredient Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson Matthey Overview List

Table Active Pharmaceutical Ingredient Business Operation of Johnson Matthey (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Hisun Pharmacy Overview List

Table Active Pharmaceutical Ingredient Business Operation of Hisun Pharmacy (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cambrex Overview List

Table Active Pharmaceutical Ingredient Business Operation of Cambrex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Shandong Xinhua Pharmaceutical Overview List

Table Active Pharmaceutical Ingredient Business Operation of Shandong Xinhua Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Lonza group Overview List

Table Active Pharmaceutical Ingredient Business Operation of Lonza group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Huahai Pharmaceutical Overview List

Table Active Pharmaceutical Ingredient Business Operation of Huahai Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Haerbin Pharmaceutical Group Overview List

Table Active Pharmaceutical Ingredient Business Operation of Haerbin Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cipla Overview List

Table Active Pharmaceutical Ingredient Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Tian Yao Overview List

Table Active Pharmaceutical Ingredient Business Operation of Tian Yao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Lupin Overview List

Table Active Pharmaceutical Ingredient Business Operation of Lupin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table North East Pharmaceutical Overview List

Table Active Pharmaceutical Ingredient Business Operation of North East Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Albemarle Overview List

Table Active Pharmaceutical Ingredient Business Operation of Albemarle (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Shandong Lukang Pharmaceutical Overview List

Table Active Pharmaceutical Ingredient Business Operation of Shandong Lukang Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Jiangsu Hengrui Medicine Overview List

Table Active Pharmaceutical Ingredient Business Operation of Jiangsu Hengrui Medicine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bachem Overview List

Table Active Pharmaceutical Ingredient Business Operation of Bachem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Active Pharmaceutical Ingredient Sales Revenue 2013-2018, by Company, in USD Million

Table Global Active Pharmaceutical Ingredient Sales Revenue Share, by Company, in USD Million

Table Global Active Pharmaceutical Ingredient Sales Volume 2013-2018, by Company, in Volume

Table Global Active Pharmaceutical Ingredient Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Active Pharmaceutical Ingredient Demand Forecast 2019-2024, by Application, in USD Million

Table Active Pharmaceutical Ingredient Demand Forecast 2019-2024, by Application, in Volume

Table Active Pharmaceutical Ingredient Production 2013-2018, by Region, in USD Million

Table Active Pharmaceutical Ingredient Production 2013-2018, by Region, in Volume

Table Global Active Pharmaceutical Ingredient Market 2013-2018, by Region, in USD Million

Table Global Active Pharmaceutical Ingredient Market Share 2013-2018, by Region, in USD Million

Table Global Active Pharmaceutical Ingredient Market 2013-2018, by Region, in Volume

Table Global Active Pharmaceutical Ingredient Market Share 2013-2018, by Region, in Volume

Table North America Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in USD Million

Table North America Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in Volume

Table Europe Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in USD Million

Table Europe Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in Volume

Table South America Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in USD Million

Table South America Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in Volume

Table Active Pharmaceutical Ingredient Market Forecast 2019-2024, by Region, in USD Million

Table Active Pharmaceutical Ingredient Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Snapshot

Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug.

The global Active Pharmaceutical Ingredient market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Active Pharmaceutical Ingredient by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Synthetic API

Biotech API

Others

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Teva

Novartis

Pfizer

Johnson & Johnson

Mylan

North China Pharmaceutical Group

Dr. Reddy's Laboratories

Roche

Aurobindo pharma

Sun Pharmaceutical Industries

Boehringer Ingelheim GmbH

Bayer

BASF

DSM

Zhejiang Medicine

Biocon

Johnson Matthey

Hisun Pharmacy

Cambrex

Shandong Xinhua Pharmaceutical

Lonza group

Huahai Pharmaceutical

Haerbin Pharmaceutical Group

Cipla

Tian Yao

Lupin

North East Pharmaceutical

Albemarle

Shandong Lukang Pharmaceutical

Jiangsu Hengrui Medicine

Bachem

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Non-steroidal Anti-inflammatory Drugs (NSAIDs)

Oncology Drugs

Anti-diabetic Drugs

Cardiovascular Drugs

Central Nervous System Drugs (CNS Drugs)

Musculoskeletal Drugs

Other Drugs

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Scope

Table of Contents

1 Industry Overview

1.1 Active Pharmaceutical Ingredient Industry

1.1.1 Overview

1.1.2 Development of Active Pharmaceutical Ingredient

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Active Pharmaceutical Ingredient Market by Type

3.1 By Type

3.1.1 Synthetic API

3.1.2 Biotech API

3.1.3 Others

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Active Pharmaceutical Ingredient Teva (Company Profile, Sales Data etc.)

4.2 Novartis (Company Profile, Sales Data etc.)

4.3 Pfizer (Company Profile, Sales Data etc.)

4.4 Johnson & Johnson (Company Profile, Sales Data etc.)

4.5 Mylan (Company Profile, Sales Data etc.)

4.6 North China Pharmaceutical Group (Company Profile, Sales Data etc.)

4.7 Dr. Reddy's Laboratories (Company Profile, Sales Data etc.)

4.8 Roche (Company Profile, Sales Data etc.)

4.9 Aurobindo pharma (Company Profile, Sales Data etc.)

4.10 Sun Pharmaceutical Industries (Company Profile, Sales Data etc.)

4.11 Boehringer Ingelheim GmbH (Company Profile, Sales Data etc.)

4.12 Bayer (Company Profile, Sales Data etc.)

4.13 BASF (Company Profile, Sales Data etc.)

4.14 DSM (Company Profile, Sales Data etc.)

4.15 Zhejiang Medicine (Company Profile, Sales Data etc.)

4.16 Biocon (Company Profile, Sales Data etc.)

4.17 Johnson Matthey (Company Profile, Sales Data etc.)

4.18 Hisun Pharmacy (Company Profile, Sales Data etc.)

4.19 Cambrex (Company Profile, Sales Data etc.)

4.20 Shandong Xinhua Pharmaceutical (Company Profile, Sales Data etc.)

4.21 Lonza group (Company Profile, Sales Data etc.)

4.22 Huahai Pharmaceutical (Company Profile, Sales Data etc.)

4.23 Haerbin Pharmaceutical Group (Company Profile, Sales Data etc.)

4.24 Cipla (Company Profile, Sales Data etc.)

4.25 Tian Yao (Company Profile, Sales Data etc.)

4.26 Lupin (Company Profile, Sales Data etc.)

4.27 North East Pharmaceutical (Company Profile, Sales Data etc.)

4.28 Albemarle (Company Profile, Sales Data etc.)

4.29 Shandong Lukang Pharmaceutical (Company Profile, Sales Data etc.)

4.30 Jiangsu Hengrui Medicine (Company Profile, Sales Data etc.)

4.31 Bachem (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Non-steroidal Anti-inflammatory Drugs (NSAIDs)

6.1.2 Demand in Oncology Drugs

6.1.3 Demand in Anti-diabetic Drugs

6.1.4 Demand in Cardiovascular Drugs

6.1.5 Demand in Central Nervous System Drugs (CNS Drugs)

6.1.6 Demand in Musculoskeletal Drugs

6.1.7 Demand in Other Drugs

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Active Pharmaceutical Ingredient Market Growth 2013-2018, by Type, in USD Million

Figure Global Active Pharmaceutical Ingredient Market Growth 2013-2018, by Type, in Volume

Figure North America Active Pharmaceutical Ingredient Market Concentration, in 2018

Figure Europe Active Pharmaceutical Ingredient Market Market Concentration, in 2018

Figure Asia-Pacific Active Pharmaceutical Ingredient MMarket Concentration, in 2018

Figure South America Active Pharmaceutical Ingredient Market Concentration, in 2018

Figure Middle East & Africa Active Pharmaceutical Ingredient Market Concentration, in 2018

Figure Active Pharmaceutical Ingredient Demand in Non-steroidal Anti-inflammatory Drugs (NSAIDs), 2013-2018, in USD Million

Figure Active Pharmaceutical Ingredient Demand in Non-steroidal Anti-inflammatory Drugs (NSAIDs), 2013-2018, in Volume

Figure Active Pharmaceutical Ingredient Demand in Oncology Drugs, 2013-2018, in USD Million

Figure Active Pharmaceutical Ingredient Demand in Oncology Drugs, 2013-2018, in Volume

Figure Active Pharmaceutical Ingredient Demand in Anti-diabetic Drugs, 2013-2018, in USD Million

Figure Active Pharmaceutical Ingredient Demand in Anti-diabetic Drugs, 2013-2018, in Volume

Figure Active Pharmaceutical Ingredient Demand in Cardiovascular Drugs, 2013-2018, in USD Million

Figure Active Pharmaceutical Ingredient Demand in Cardiovascular Drugs, 2013-2018, in Volume

Figure Active Pharmaceutical Ingredient Demand in Central Nervous System Drugs (CNS Drugs), 2013-2018, in USD Million

Figure Active Pharmaceutical Ingredient Demand in Central Nervous System Drugs (CNS Drugs), 2013-2018, in Volume

Figure Active Pharmaceutical Ingredient Demand in Musculoskeletal Drugs, 2013-2018, in USD Million

Figure Active Pharmaceutical Ingredient Demand in Musculoskeletal Drugs, 2013-2018, in Volume

Figure Active Pharmaceutical Ingredient Demand in Other Drugs, 2013-2018, in USD Million

Figure Active Pharmaceutical Ingredient Demand in Other Drugs, 2013-2018, in Volume

Figure North America Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in USD Million

Figure North America Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in Volume

Figure Europe Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in USD Million

Figure Europe Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in Volume

Figure South America Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in USD Million

Figure South America Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Active Pharmaceutical Ingredient Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Active Pharmaceutical Ingredient

Table Application Segment of Active Pharmaceutical Ingredient

Table Global Active Pharmaceutical Ingredient Market 2013-2024, by Application, in USD Million

Table Major Company List of Synthetic API

Table Major Company List of Biotech API

Table Major Company List of Others

Table Global Active Pharmaceutical Ingredient Market 2013-2018, by Type, in USD Million

Table Global Active Pharmaceutical Ingredient Market 2013-2018, by Type, in Volume

Table Global Active Pharmaceutical Ingredient Market Forecast 2019-2024, by Type, in USD Million

Table Global Active Pharmaceutical Ingredient Market Forecast 2019-2024, by Type, in Volume

Table Teva Overview List

Table Active Pharmaceutical Ingredient Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Active Pharmaceutical Ingredient Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Active Pharmaceutical Ingredient Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Active Pharmaceutical Ingredient Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mylan Overview List

Table Active Pharmaceutical Ingredient Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table North China Pharmaceutical Group Overview List

Table Active Pharmaceutical Ingredient Business Operation of North China Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Dr. Reddy's Laboratories Overview List

Table Active Pharmaceutical Ingredient Business Operation of Dr. Reddy's Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Roche Overview List

Table Active Pharmaceutical Ingredient Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Aurobindo pharma Overview List

Table Active Pharmaceutical Ingredient Business Operation of Aurobindo pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sun Pharmaceutical Industries Overview List

Table Active Pharmaceutical Ingredient Business Operation of Sun Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Boehringer Ingelheim GmbH Overview List

Table Active Pharmaceutical Ingredient Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayer Overview List

Table Active Pharmaceutical Ingredient Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table BASF Overview List

Table Active Pharmaceutical Ingredient Business Operation of BASF (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table DSM Overview List

Table Active Pharmaceutical Ingredient Business Operation of DSM (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Zhejiang Medicine Overview List

Table Active Pharmaceutical Ingredient Business Operation of Zhejiang Medicine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Biocon Overview List

Table Active Pharmaceutical Ingredient Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson Matthey Overview List

Table Active Pharmaceutical Ingredient Business Operation of Johnson Matthey (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Hisun Pharmacy Overview List

Table Active Pharmaceutical Ingredient Business Operation of Hisun Pharmacy (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cambrex Overview List

Table Active Pharmaceutical Ingredient Business Operation of Cambrex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Shandong Xinhua Pharmaceutical Overview List

Table Active Pharmaceutical Ingredient Business Operation of Shandong Xinhua Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Lonza group Overview List

Table Active Pharmaceutical Ingredient Business Operation of Lonza group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Huahai Pharmaceutical Overview List

Table Active Pharmaceutical Ingredient Business Operation of Huahai Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Haerbin Pharmaceutical Group Overview List

Table Active Pharmaceutical Ingredient Business Operation of Haerbin Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cipla Overview List

Table Active Pharmaceutical Ingredient Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Tian Yao Overview List

Table Active Pharmaceutical Ingredient Business Operation of Tian Yao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Lupin Overview List

Table Active Pharmaceutical Ingredient Business Operation of Lupin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table North East Pharmaceutical Overview List

Table Active Pharmaceutical Ingredient Business Operation of North East Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Albemarle Overview List

Table Active Pharmaceutical Ingredient Business Operation of Albemarle (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Shandong Lukang Pharmaceutical Overview List

Table Active Pharmaceutical Ingredient Business Operation of Shandong Lukang Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Jiangsu Hengrui Medicine Overview List

Table Active Pharmaceutical Ingredient Business Operation of Jiangsu Hengrui Medicine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bachem Overview List

Table Active Pharmaceutical Ingredient Business Operation of Bachem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Active Pharmaceutical Ingredient Sales Revenue 2013-2018, by Company, in USD Million

Table Global Active Pharmaceutical Ingredient Sales Revenue Share, by Company, in USD Million

Table Global Active Pharmaceutical Ingredient Sales Volume 2013-2018, by Company, in Volume

Table Global Active Pharmaceutical Ingredient Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Active Pharmaceutical Ingredient Demand Forecast 2019-2024, by Application, in USD Million

Table Active Pharmaceutical Ingredient Demand Forecast 2019-2024, by Application, in Volume

Table Active Pharmaceutical Ingredient Production 2013-2018, by Region, in USD Million

Table Active Pharmaceutical Ingredient Production 2013-2018, by Region, in Volume

Table Global Active Pharmaceutical Ingredient Market 2013-2018, by Region, in USD Million

Table Global Active Pharmaceutical Ingredient Market Share 2013-2018, by Region, in USD Million

Table Global Active Pharmaceutical Ingredient Market 2013-2018, by Region, in Volume

Table Global Active Pharmaceutical Ingredient Market Share 2013-2018, by Region, in Volume

Table North America Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in USD Million

Table North America Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in Volume

Table Europe Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in USD Million

Table Europe Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in Volume

Table South America Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in USD Million

Table South America Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Active Pharmaceutical Ingredient Market Size 2013-2018, by Country, in Volume

Table Active Pharmaceutical Ingredient Market Forecast 2019-2024, by Region, in USD Million

Table Active Pharmaceutical Ingredient Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

To know more information on Purchase by Section, please send a mail to support@kenresearch.com